Portal de Periódicos da CAPES

Unexpected delayed‐type hypersensitivity skin reactions to the ultra‐low‐molecular‐weight heparin fondaparinux

2005; Wiley; Volume: 60; Issue: 3 Linguagem: Inglês

10.1111/j.1398-9995.2005.00695.x

1398-9995

J. Maetzke, R. Hinrichs, Leonhard‐Moritz Schneider, Karin Scharffetter‐­Kochanek,

Intramuscular injections and effects

AllergyVolume 60, Issue 3 p. 413-415 Unexpected delayed-type hypersensitivity skin reactions to the ultra-low-molecular-weight heparin fondaparinux J. Maetzke, J. Maetzke Department of Dermatology University of Ulm Maienweg 12 89081 Ulm, Germany Tel: +49-731-21801 Fax: +49-731-21870 E-mail: [email protected]Search for more papers by this authorR. Hinrichs, R. Hinrichs Department of Dermatology University of Ulm Maienweg 12 89081 Ulm, Germany Tel: +49-731-21801 Fax: +49-731-21870 E-mail: [email protected]Search for more papers by this authorL.-A. Schneider, L.-A. Schneider Department of Dermatology University of Ulm Maienweg 12 89081 Ulm, Germany Tel: +49-731-21801 Fax: +49-731-21870 E-mail: [email protected]Search for more papers by this authorK. Scharffetter-Kochanek, K. Scharffetter-Kochanek Department of Dermatology University of Ulm Maienweg 12 89081 Ulm, Germany Tel: +49-731-21801 Fax: +49-731-21870 E-mail: [email protected]Search for more papers by this author J. Maetzke, J. Maetzke Department of Dermatology University of Ulm Maienweg 12 89081 Ulm, Germany Tel: +49-731-21801 Fax: +49-731-21870 E-mail: [email protected]Search for more papers by this authorR. Hinrichs, R. Hinrichs Department of Dermatology University of Ulm Maienweg 12 89081 Ulm, Germany Tel: +49-731-21801 Fax: +49-731-21870 E-mail: [email protected]Search for more papers by this authorL.-A. Schneider, L.-A. Schneider Department of Dermatology University of Ulm Maienweg 12 89081 Ulm, Germany Tel: +49-731-21801 Fax: +49-731-21870 E-mail: [email protected]Search for more papers by this authorK. Scharffetter-Kochanek, K. Scharffetter-Kochanek Department of Dermatology University of Ulm Maienweg 12 89081 Ulm, Germany Tel: +49-731-21801 Fax: +49-731-21870 E-mail: [email protected]Search for more papers by this author First published: 28 January 2005 https://doi.org/10.1111/j.1398-9995.2005.00695.xCitations: 20 Delayed-type hypersensitivity to fondaparinux. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Koch P, Münßinger T, Rupp-John C, Uhl K. Delayed-type hypersensitivity skin reactions by subcutaneous unfractionated and low molecular-weight heparins: tolerance of a new recombinant hirudin. J Am Acad Dermatol 2000; 42: 612–619. 2 Schiffner R, Glaessl A, Landthaler M, Stolz W. Tolerance of desirudin in a patient with generalized eczema after intravenous challenge with heparin and a delayed-type skin reaction to high and low molecular weight heparins and danaparoid. Contact Dermat 2000; 42: 49. 3 Bircher AJ, Flückinger R, Büchner SA. Eczematous infiltrated plaque to subcutaneous heparin: a type IV allergic reaction. Br J Dermatol 1990; 123: 507–514. 4 Hunzelmann N, Gold H, Scharffetter-Kochanek K. Concomitant sensitisation to high and low molecular-weight heparins, heparinoids and pentosanpolysulfate. Contact Dermat 1998; 39: 88–89. 5 Grassegger A, Fritsch P, Reider N. Delayed-type hypersensitity and cross-reavtivity to heparins and danaparoid: a prospective study. Dermatol Surg 2001; 27: 47–52. 6 Fields RM, Peppo W. The use of intravenous recombinant hirudin in the treatment of deap vein thrombosis in a patient with an acute heparin allergy. Ann Emerg Med 2002; 40: 155–158. 7 Maetzke J, Hinrichs R, Staib G, Scharffetter-Kochanek K. Fondaparinux as a novel therapeutic alternative in a patient with heparin allergy. Allergy 2004; 59: 237–238. 8 Sacher C, Hunzelmann N. Tolerance to the synthetic pentasaccharide fondaparinux in heparin sensitisation. Allergy 2003; 58: 1318–1319. Citing Literature Volume60, Issue3March 2005Pages 413-415 ReferencesRelatedInformation